Grant advances Endece’s research

Thanks to a $250,000 grant from the National Multiple Sclerosis Society, Endece Neural, a subsidiary company of Mequon-based drug discovery company Endece LLC, is forging ahead with preclinical research of a drug compound that it believes could revolutionize treatment options for people living with multiple sclerosis (MS).

Read the full story here, in the Oct. 28 issue of BizTimes Milwaukee magazine.

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display